Advertisement
Perspective

Perspective Perspectives are commissioned from an expert and discuss the clinical practice or public health implications of a published study. The original publication must be freely available online.

See all article types »

A New Deal for Global Health R&D? The Recommendations of the Consultative Expert Working Group on Research and Development (CEWG)

  • John-Arne Røttingen mail,

    John-Arne.Rottingen@kunnskapssenteret.no

    Affiliations: Department of Health Management and Health Economics, Institute for Health and Society, University of Oslo, Oslo, Norway, Harvard Kennedy School, Harvard University, Cambridge, Massachusetts, United States of America

    X
  • Claudia Chamas

    Affiliation: Centre for Technological Development in Health, Fiocruz, Rio de Janeiro, Brazil

    X
  • Published: May 15, 2012
  • DOI: 10.1371/journal.pmed.1001219

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

Innovation and Access to Medicines for Neglected Populations: Could a Treaty Address a Broken Pharmaceutical R&D System?

Suerie Moon, Jorge Bermudez, Ellen 't Hoen
Essay | published 15 May 2012 | PLOS Medicine
doi:10.1371/journal.pmed.1001218